A new drug called Amyvid may help doctors give patients suffering from Alzheimer’s-like symptoms some clarity they desperately want: a conclusive diagnosis. Clifford Saper, chairman of the Department of Neurology at Beth Israel Deaconess Medical Center, is quoted.
